IDEXX Laboratories, Inc. ( IDXX) - Stock Earnings
IDXX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
IDXX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 248.2 million USD | 1.1 billion USD |
| 2026Q1 | 278.4 million USD | 1.1 billion USD |
| 2026Q2 | 338.4 million USD | 1.2 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IDXX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 845.0 million USD | 3.7 billion USD |
| 2024 | 887.9 million USD | 3.9 billion USD |
| 2025 | 1.1 billion USD | 4.3 billion USD |
| 2026 Est. | — | — |
IDXX
Price: $518
Earnings Per Share: 14.26 USD
P/E Ratio: 41.14
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 353885
Ebitda: 120.9 millionMarket Capitalization: 41.6 billion